Novotech, an Asia Pacific centered biotech CRO will be at BIO Europe (March 20-22, 2023) to meet with clinical stage biotechs and to share the benefits of Novotech’s recently expanded operations in Europe. Novotech announced at JPMorgan that it had acquired EastHORN, a European CRO with clinical, medical and regulatory expertise in multiple strategically important locations across the continent. Meanwhile, EastHORN which is retaining its brand, is now a Novotech company and is integrating ...